Labeler · US market

Ascent Pharmaceuticals, Inc.

Ascent Pharmaceuticals, Inc. is a US drug labeler with US FDA registrations covering 8 drug concepts (8 currently active) across 34 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes43602

Active drugs8

Registrations17 active / 17

Packages34

Sole supplier of0 drugs

Portfolio8 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Hydromorphone Hydrochloride tablet	rx	3	6	SUPPLYING
Sertraline Hydrochloride tablet	rx	3	6	SUPPLYING
Escitalopram tablet	rx	3	6	SUPPLYING
Oxycodone Hydrochloride solution	rx	2	4	SUPPLYING
Famotidine tablet	rx	2	4	SUPPLYING
Methylphenidate Hydrochloride solution	rx	2	4	SUPPLYING
Ibuprofen And Famotidine tablet	rx	1	3	SUPPLYING
Hydromorphone Hydrochloride solution	rx	1	1	SUPPLYING

At a glance

TypeLabeler
Labeler codes43602
Filing names1
Drugs (active)8
Drugs (all time)8
US registrations17
Packages34

Recent events

Shortages, recalls, and registration changes across all filing names.

Nov 19, 2021
RECALLRecall (Class II): Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manufactured for: Camber…
Oct 26, 2020
RECALLRecall (Class II): Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only, Manufactured for : Camber…
Jan 22, 2018
RECALLRecall (Class III): Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber Pharmaceuticals, Inc., …

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.